ArticleRheumatology advances in practice2026
Nurse-supported self-monitoring of serum urate by gout patients using a treat-to-target approach: a feasibility study.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Keeping gout on target with nurse-supported urate self-monitoring.Nature reviews. Rheumatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the feasibility of a nurse-supported, treat-to-target (T2T) self-monitoring approach for gout patients initiating urate-lowering therapy (ULT) using point-of-care testing (POCT) of serum urate (SU) levels. Methods: A 24-week prospective feasibility study was conducted at the Sint Maartenskliniek in the Netherlands among 32 patients starting ULT, or recently started ULT and not at target. Participants received a POCT device to self-measure SU levels at home and report results every 4 weeks via a digital platform. Nurses provided education and dosing advice based on SU levels and monitored patient follow-up. Feasibility was assessed using Bowen's framework. Patient data were obtained through questionnaires and chart review, and stakeholder perspectives were collected through semi-structured interviews. Results: Patients found the intervention highly acceptable. Adherence to SU measurements was 93%, with minimal burden and few problems reported. The majority of the patients reached their SU target (75%). Patients had a median of 2 gout flares (interquartile range [IQR] 0-3). Stakeholders valued the intervention for the potential to increase patient engagement and care efficiency, though they emphasized the need for evidence on cost-effectiveness, clear protocols and appropriate patient selection. Conclusion: Nurse-supported self-monitoring for gout was acceptable, feasible and practical in this selected group of gout patients. The short-term SU target attainment was encouraging, warranting larger comparative randomized studies with longer follow-up to establish (cost-) effectiveness, and long-term disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.